InstalabANA Screen
Should you take a ANA Screen test?
This test is most useful if any of these apply to you.
3 Biomarkers Included
- ANA ScreenThe yes-or-no reading for antibodies against your own cell nuclei (antinuclear antibodies, or ANA). It is highly sensitive, so a negative result makes lupus unlikely.A positive screen flags possible autoimmune activity but needs the titer, pattern, and your symptoms to mean anything.
- ANA TiterMeasures how concentrated the antibodies are, reported as a dilution. It separates the common, weak positives seen in healthy people from stronger results more likely to signal disease.A high titer such as 1:320 or above carries far more diagnostic weight than a borderline 1:40 or 1:80.
- ANA PatternDescribes the shape the antibodies make under a fluorescent microscope, which points toward the likely specific antibody and disease.The pattern directs which confirmatory antibody test to order next, such as anti-dsDNA for a homogeneous pattern.
About ANA Screen
Autoimmune diseases like lupus and Sjögren's can simmer for years as vague complaints, including fatigue, aching joints, dry eyes, and odd rashes, before anyone gives them a name. This panel looks for the immune system's calling card: antibodies aimed at the nucleus of your own cells (called antinuclear antibodies, or ANA).
A result here is only the opening line of the story, not the whole plot. This panel reports the finding three ways, and it is the combination of those three readings that separates a meaningful signal from ordinary background noise.
What This Panel Reveals
All three readings come from a single tube of blood run through one laboratory test, so this is really one measurement described from three angles. The screen answers whether these self-targeting antibodies are present at all. Because it catches the vast majority of cases, a negative screen is genuinely reassuring for lupus.
The titer answers how concentrated those antibodies are, reported as a dilution such as 1:80 or 1:320. This matters because low-level positives are common in perfectly healthy people, while higher concentrations carry more diagnostic weight.
The pattern answers which antibodies are most likely present, based on the shape the antibodies make under a fluorescent microscope. A homogeneous (evenly stained) pattern leans toward lupus, a speckled pattern toward a broad group of antibodies against nuclear proteins (seen in Sjögren's, lupus, and mixed connective tissue disease), and a centromere or nucleolar pattern toward scleroderma. The pattern is what tells a clinician which specific antibody test to order next.
How to Read Your Results Together
No single reading stands on its own. The value comes from reading presence, strength, and pattern side by side, and always against your actual symptoms. In an international study of 805 people newly diagnosed with lupus, 96.1% to 98.3% tested positive, which is why a clean negative result is worth so much. On the other side, roughly 10% to 12% of healthy adults test positive at 1:80 (estimates vary by population and can run higher), about 5% at 1:160, and about 3% at 1:320, so a weak positive in someone who feels well often means very little.
| Your result | What it suggests |
|---|---|
| Negative screen | Lupus becomes unlikely, though some other autoimmune diseases can still be present. |
| Positive, low titer (1:40 to 1:80), no symptoms | Common in healthy people and usually not a sign of disease by itself. |
| Positive, high titer (1:320 or above), with symptoms | More likely to be meaningful and worth specific antibody follow-up. |
| Homogeneous pattern | Points toward antibodies against double-stranded DNA (anti-dsDNA) and lupus. |
Strength climbs the ladder. In one study of 1,297 people, a positive result became far less likely to be a false alarm as the titer rose: specificity (the share of people without lupus who correctly test negative) climbed from 81.29% at the lowest positive level to 90.69% and then 96.52% at the highest. Even so, the raw odds depend heavily on who is tested: among patients referred to a specialist for a positive result, only 2.1% turned out to have lupus and 9.1% had any autoimmune connective tissue disease.
What to Do with Your Results
A positive result alongside real symptoms is a reason to go further, not a diagnosis. The natural next step is specific antibody testing guided by your pattern (anti-dsDNA and complement proteins for lupus, SS-A and SS-B for Sjögren's, Scl-70 for scleroderma), usually with a rheumatologist. If your screen is negative but symptoms persist, some of these specific antibodies can still be present, so the workup does not always stop at a negative ANA.
This is a diagnostic test, not a tracking dial. Repeating it to follow disease activity adds little, since one audit found 67% of repeat results were unchanged, and the antibody level does not move reliably with how you feel. Repeat it only if your symptoms change in a way that raises a new question, such as new organ involvement or a suspected second autoimmune condition.
When Results Can Be Misleading
Several things can nudge every reading in this panel at once. Positive results turn up more often with older age, in women, during infections, in some cancers and liver or thyroid conditions, and with certain drugs such as hydralazine, procainamide, and minocycline. This is why the test is meant for people with symptoms, not as a blanket screen for those who feel fine.
The measurement itself is not perfectly reproducible. The same blood can yield a slightly different titer or pattern from one laboratory to another, and pattern reading depends partly on the person at the microscope. Treat a one-step difference in titer between draws as likely noise rather than a real change.